CellGenix registers FDA Drug Master Files for ex-vivo CellGro® TNF-a and GM-CSF
Together with further quality and safety features, like animal-derived-free raw materials or batch-specific certificates-of-analysis, CellGenix´ ex-vivo grade cytokines fulfil all major recommendations given in USP 1043.
The cytokines are produced under cGMP-conditions, expressed in E-coli and no animal derived raw materials are used in the production or purification process. TNF-a and GM-CSF are intended for ex-vivo use only. Batch-specific Certificates of Analysis are issued and sent with each delivery.
CellGenix has filed these two DMFs which enable an investigator, upon written approval of CellGenix, to cross-reference either DMF in their own sponsored IND-application using ex-vivo processed cells in clinical research.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.